Nanjing Bioheng Biotech Co., Ltd.
Clinical trials sponsored by Nanjing Bioheng Biotech Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Immune reset: CAR-T cells take on lupus and more Results expected Dec 2026 (estimated)
- Immune reset: CAR-T therapy targets lupus, MS, and more Results expected Jan 2027 (estimated)
- Experimental CAR-T therapy takes on lupus and more Results expected Jul 2027 (estimated)